Optimizing MIGS for Practice and Center Success - Takeaways - MDSpire

Optimizing MIGS for Practice and Center Success

The key is execution, understanding the clinical landscape, controlling device cost, engineering the intraoperative workflow, and scheduling/staffing with intention.

  • By

  • Mitchell C. Shultz, MD

  • July 1, 2026

  • 9 min

Share

  • 1

    Minimally invasive glaucoma surgery (MIGS) is essential for enhancing clinical outcomes and operational efficiency in ambulatory surgical centers (ASCs).

  • 2

    MIGS complements high-volume cataract surgery and can be performed with minimal disruption, often taking only 3-8 additional minutes.

  • 3

    The iStent Infinite and Hydrus Microstent are FDA-cleared devices for treating refractory primary open-angle glaucoma in adults.

  • 4

    Operational efficiency in ASCs is crucial for profitability, and MIGS can be integrated without significantly affecting surgical schedules.

  • 5

    Sustained-release drug delivery systems like iDose TR and Durysta provide long-term intraocular pressure control and address patient compliance.

Original Source(s)

Optimizing MIGS for Practice and Center Success

  • by Mitchell C. Shultz, MD

  • July 1, 2026

Related Content

The Evolving Glaucoma Toolbox

Justin Schweitzer, OD, FAAO, and Jessica Steen, OD, FAAO, describe emerging technologies, treatment strategies, and clinical considerations that can help eyecare professionals (ECPs) identify glaucoma earlier and better manage progression.

The Unmeasured Burden of Glaucoma

What do glaucoma patients talk about outside of the clinic?

Improving Glaucoma Detection in Zambia

Study details how low-cost training can improve glaucoma disc assessment in low-resource settings

  • June 18, 2026

  • 2 min